Published in Clin Exp Immunol on October 01, 1977
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest (1979) 1.19
Cells that mediate NK like cytotoxicity are present in the human delayed type hypersensitivity response. Clin Exp Immunol (1984) 0.88
Immunological behaviour following rubella infection. Clin Exp Immunol (1979) 0.80
Amino acid metabolism in mammalian cell cultures. Science (1959) 55.21
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest (1974) 3.24
Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature (1970) 2.40
Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum (1973) 2.40
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum (1972) 1.88
Tuberculin-induced migration inhibition of human peripheral leucocytes in agarose medium. Acta Allergol (1971) 1.87
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum (1975) 1.73
Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol (1973) 1.58
Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes. J Exp Med (1975) 1.55
A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med (1975) 1.50
B cell and T cell lymphopenia in systemic lupus erythematosus. Cell Immunol (1974) 1.49
Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med (1973) 1.45
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum (1975) 1.39
Cell-mediated immunity in rheumatoid arthritis. Ann Rheum Dis (1977) 1.21
Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis (1968) 1.15
Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09
Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatol Scand (1971) 1.08
The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA. Arthritis Rheum (1967) 1.05
Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest (1972) 0.98
Lymphocyte responsiveness in systemic lupus erythematosus. Arthritis Rheum (1976) 0.96
Cellular immunity in systemic lupus erythematosus. Arthritis Rheum (1974) 0.91
Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing age. J Lab Clin Med (1975) 0.82
Leucocyte migration-inhibition in systemic lupus erythematosus. Ann Rheum Dis (1974) 0.78
Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication. Schweiz Med Wochenschr (1971) 0.77
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell (1995) 11.86
A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (1991) 6.54
TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell (2000) 6.07
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci U S A (1992) 5.24
AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem (1999) 4.49
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A (1997) 3.83
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (1997) 3.73
Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum (1972) 3.43
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J (1997) 3.34
Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem (1998) 3.25
Recombinants between endogenous and exogenous avian tumor viruses: role of the C region and other portions of the genome in the control of replication and transformation. J Virol (1980) 2.93
The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol (1996) 2.87
At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses. Proc Natl Acad Sci U S A (1982) 2.84
A common region for proviral DNA integration in MoMuLV-induced rat thymic lymphomas. Nature (1983) 2.84
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol (2001) 2.81
How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum (1985) 2.68
Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol (1997) 2.67
Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol (1996) 2.64
Molecular cloning of avian myelocytomatosis virus (MC29) transforming sequences. Proc Natl Acad Sci U S A (1981) 2.59
Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med (1974) 2.47
Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature (1970) 2.40
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38
Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol (1993) 2.37
The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene (1993) 2.05
AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol Cell Biol (1995) 2.03
Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc Natl Acad Sci U S A (1994) 2.00
Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J Biol Chem (1996) 1.97
Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc Natl Acad Sci U S A (1993) 1.95
Sequence comparison in the crossover region of an oncogenic avian retrovirus recombinant and its nononcogenic parent: genetic regions that control growth rate and oncogenic potential. Mol Cell Biol (1982) 1.89
Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum (1998) 1.87
p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mol Cell Biol (1999) 1.83
Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. Arthritis Rheum (1995) 1.82
Subgroup-E avian-leukosis-virus-associated disease in chickens. Cold Spring Harb Symp Quant Biol (1980) 1.79
Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis. J Rheumatol (2000) 1.78
Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB. Oncogene (1998) 1.77
Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus. Nucleic Acids Res (1985) 1.76
Variation in avian retrovirus genomes. Ann N Y Acad Sci (1980) 1.75
Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene (2001) 1.70
Concerted DNA rearrangements in Moloney murine leukemia virus-induced thymomas: a potential synergistic relationship in oncogenesis. J Virol (1985) 1.67
Role of the C region in relative growth rates of endogenous and exogenous avian oncoviruses. Cold Spring Harb Symp Quant Biol (1980) 1.67
Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc Natl Acad Sci U S A (1990) 1.63
Infectious arthritis. Arch Intern Med (1979) 1.61
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev (1997) 1.57
The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol (1998) 1.57
PDK2: a complex tail in one Akt. Sci STKE (2001) 1.50
Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene (1993) 1.49
Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci U S A (2001) 1.47
The first recognition of the association between goiter and exophthalmos. J Endocrinol Invest (1983) 1.47
Scoring radiographic abnormalities in rheumatoid arthritis. J Rheumatol (1989) 1.45
Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) (1976) 1.44
A novel plant glutathione S-transferase/peroxidase suppresses Bax lethality in yeast. J Biol Chem (2000) 1.44
Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities. Arthritis Rheum (1982) 1.43
Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum (1971) 1.42
The syndrome of primary orthostatic hypotension. Brain (1969) 1.41
Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol (1998) 1.41
Contamination of flexible fiberoptic bronchoscopes. Am Rev Respir Dis (1983) 1.40
Radiographic evaluation of the course of articular disease. Clin Rheum Dis (1983) 1.39
T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications. J Virol (1990) 1.39
Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization. J Biol Chem (2000) 1.39
Bacteriuria and survival in old age. N Engl J Med (1981) 1.39
Target sites for the transposition of rat long interspersed repeated DNA elements (LINEs) are not random. Nucleic Acids Res (1986) 1.38
The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci U S A (1996) 1.38
Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1988) 1.35
Genomes of endogenous and exogenous avian retroviruses. Virology (1983) 1.33
Relative contributions of rib cage and abdomen to breathing in normal subjects. J Appl Physiol (1975) 1.28
Mycoplasmas and arthritis. Arthritis Rheum (1970) 1.27
Insertion of long interspersed repeated elements at the Igh (immunoglobulin heavy chain) and Mlvi-2 (Moloney leukemia virus integration 2) loci of rats. Proc Natl Acad Sci U S A (1985) 1.26
The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc Natl Acad Sci U S A (1998) 1.26
Mutant and recombinant avian retroviruses with extended host range. Proc Natl Acad Sci U S A (1980) 1.25
Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival. Mol Cell Biol (1999) 1.21
Cell-mediated immunity in rheumatoid arthritis. Ann Rheum Dis (1977) 1.21
Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann Intern Med (1975) 1.21
Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum (1985) 1.20
Respiratory muscle strength in congestive heart failure. Chest (1990) 1.20
Oncogenesis by Moloney murine leukemia virus. Anticancer Res (1987) 1.20
Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG. J Clin Invest (1975) 1.20
Hepatitis-associated antigen in chronic liver disease. Lancet (1970) 1.19
Cellular DNA region involved in induction of thymic lymphomas (Mlvi-2) maps to mouse chromosome 15. Mol Cell Biol (1984) 1.18
Primary sleep apnoea syndrome. J Neurol Neurosurg Psychiatry (1981) 1.15
Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum (1986) 1.15
Provirus insertion in Tpl-1, an Ets-1-related oncogene, is associated with tumor progression in Moloney murine leukemia virus-induced rat thymic lymphomas. Proc Natl Acad Sci U S A (1989) 1.14
Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion. J Virol (1993) 1.14
Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1980) 1.13
Attempts to apply curve fitting models to the analysis of progression of radiographic damage in rheumatoid arthritis are laudable, but are the results believable? J Rheumatol (1994) 1.11
CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J Biol Chem (1999) 1.11
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis (2008) 1.10
The Mlvi-1 locus involved in the induction of rat T-cell lymphomas and the pvt-1/Mis-1 locus are identical. J Virol (1989) 1.10
Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med (1987) 1.10
Sequences in the gag-pol-5'env region of avian leukosis viruses confer the ability to induce osteopetrosis. Virology (1985) 1.10
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res (2000) 1.06
Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes (1999) 1.06
A longitudinal study of bronchitic symptoms and spirometry in a middle-aged, male, industrial population. Am Rev Respir Dis (1973) 1.06
The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking. Am Rev Respir Dis (1984) 1.05
Thoracoabdominal motion in chronic obstructive pulmonary disease. Am Rev Respir Dis (1977) 1.05